Every year, the global pharmaceutical industry produces trillions of doses of medications. Manufacturing these drugs involves ...
The biotech industry has long operated on a simple premise: FDA-regulated, evidence-based science determines how medicines reach patients, not litigation. That premise was already tested in an earlier ...
A former CEO, who also led one of the industry’s top trade groups, spoke to an audience of professionals and Rutgers Business School students about the troubling challenges that come as technology ...
Join us for Open Doors – As the biopharma landscape accelerates through scientific innovation, economic pressures, and evolving global dynamics, where should companies place their bets to drive ...
Germany's chemical and pharmaceutical industry saw production and sales decline in the first half of 2026 and investment falling for a third consecutive year, the industry's VCI association said on ...
The 43rd National Pharmaceutical Industry Information Annual Conference and the 2026 Beijing · Changping Life Science Forum opened at Beijing Changping Future Science City on July 12. A Media Snippet ...
On April 2, President Donald Trump announced a 10% tariff on imports from all countries, effective on April 5. However, pharmaceuticals appear to be among the exemptions listed in the full executive ...
As Europe experienced one of its hottest Junes on record, with prolonged heatwaves reinforcing the urgency of climate action, leaders from the pharmaceutical industry and academia gathered in Zurich ...
Following the landmark success of CPHI & PMEC China in June 2026, which welcomed an unprecedented gathering of industry professionals and fostered pivotal connections across the pharmaceutical supply ...
President Trump has announced that “major” pharmaceutical product tariffs are likely to be revealed soon, but at the same time, paused broader tariffs for most trade partners for 90 days to allow time ...
To paraphrase the old British joke, industrial revolutions are like buses: You wait for one and then two come along at once. In biopharma, the two revolutions are Biopharma 4.0 and Biopharma 5.0.
Cue Biopharma (CUE) has appointed Dominic Borie as Chief Medical Officer and head of research & development. Borie brings more than two decades of experience leading research and clinical development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results